RESTON,
Va., Dec. 11, 2024 /PRNewswire/
-- Leidos (NYSE: LDOS) today announced a $2.5 million donation to The Children's Inn at
the National Institutes of Health (NIH). The contribution will
support renovations and expansions that will increase The
Children's Inn's capacity to serve young patients and their
families participating in pediatric research. In recognition of
this gift, The Inn's new porte-cochère – the welcoming main
entrance for families and visitors – will bear the Leidos name.
"For more than two decades, Leidos has stood alongside The
Children's Inn, championing its mission to create a place like home
for children and families fighting rare and complex diseases," said
Leidos CEO, Tom Bell. "This donation
reflects our deep commitment to advancing medical research and
supporting the courageous families who inspire us every day."
The gift supports The Children's Inn's $50 million Building
Extraordinary capital campaign, which aims to enhance
facilities and services for the growing number of patients
partnering with NIH researchers to tackle rare and serious
diseases. Once completed in 2027, the expansion will increase The
Children's Inn's capacity by 25%, accommodating up to 3,000
patients annually.
"As a company dedicated to delivering innovative health
solutions, we are honored to deepen our partnership with The
Children's Inn," said Liz Porter,
Leidos Health & Civil Sector president. "This transformative
project strengthens essential support for families while driving
the advancement of life-changing medical discoveries."
The donation underscores Leidos' mission-driven focus on
advancing health and clinical research in collaboration with the
U.S. Department of Health and Human Services (HHS). It also
highlights Leidos' long-standing partnership with The Children's
Inn, reflecting decades of support that includes volunteer work,
board leadership, financial sponsorships, and program
engagement.
"Leidos has been a fundamental pillar of support for The
Children's Inn for more than 20 years, and its ongoing support has
made an indelible impact on the lives of countless families," said
The Inn's CEO Jennie Lucca. "This
donation will help bring our vision for The Inn of Tomorrow to
life, providing an even more welcoming and supportive environment
for children and families who come to the NIH for life-saving
treatments. Leidos' generosity is a testament to its belief in the
power of innovation and compassion to change lives."
This donation builds on Leidos' recent contributions to Drake
State Community & Technical College and Hampton University, further demonstrating the
company's broader commitment to improving lives in the communities
it serves.
About Leidos
Leidos is a Fortune 500® innovation company rapidly
addressing the world's most vexing challenges in national security
and health. The company's global workforce of 48,000 collaborates
to create smarter technology solutions for customers in heavily
regulated industries. Headquartered in Reston, Virginia, Leidos reported annual
revenues of approximately $15.4
billion for the fiscal year ended December 29, 2023. For more information, visit
www.leidos.com.
About The Children's Inn
The Children's Inn at NIH is a private, nonprofit "Place Like
Home" for children and their families participating in pediatric
research at the National Institutes of Health Clinical Center, the
world's premier biomedical research hospital. The Inn reduces the
burden of illness through therapeutic, educational, and
recreational programming at no cost to families. Since opening in
1990, more than 16,000 families from around the world and all 50
states have made The Inn their home during clinical trials. As a
partner in discovery and care with the NIH, The Inn strives for the
day when no family endures the heartbreak of a seriously ill
child.
The NIH Clinical Center is at the forefront of a new era of
promising pediatric research. As the world leader in rare disease
research, the NIH is positioned to make significant breakthroughs
in treating rare inherited diseases, most of which continue to lack
a safe, effective treatment. The Clinical Center has about 1,500
active protocols, one-third of which include children. Propelled by
advances in gene therapy and cellular engineering, NIH researchers
anticipate advanced treatments and even cures for some rare genetic
diseases on the horizon.
Contact:
Alyssa Pettus
(571) 992-5499
alyssa.t.pettus@leidos.com
Victor Melara
(703) 431-4612
victor.a.melara@leidos.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/leidos-donates-2-5-million-to-the-childrens-inn-at-nih-to-expand-support-for-pediatric-research-302328976.html
SOURCE Leidos